PARPBP overexpression is associated with hyperproliferation in pancreatic cancers, hepatocellular carcinoma, and myeloid leukemia (Piao et al, 2011; O’Connor et al, 2013; Nicolae et al, 2019; Yu et al, 2019). Here, PARPBP is linked to myeloid leukemia.